BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 29173910)

  • 1. EPID-based in vivo dosimetry for stereotactic body radiotherapy of non-small cell lung tumors: Initial clinical experience.
    Consorti R; Fidanzio A; Brainovich V; Mangiacotti F; De Spirito M; Mirri MA; Petrucci A
    Phys Med; 2017 Oct; 42():157-161. PubMed ID: 29173910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epid-based in vivo dose verification for lung stereotactic treatments delivered with multiple breath-hold segmented volumetric modulated arc therapy.
    Cilla S; Ianiro A; Craus M; Viola P; Deodato F; Macchia G; Buwenge M; Morganti AG; Valentini V; Piermattei A
    J Appl Clin Med Phys; 2019 Mar; 20(3):37-44. PubMed ID: 30790439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors.
    Cilla S; Meluccio D; Fidanzio A; Azario L; Ianiro A; Macchia G; Digesù C; Deodato F; Valentini V; Morganti AG; Piermattei A
    Phys Med; 2016 Jan; 32(1):52-8. PubMed ID: 26511150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of  interfraction setup variations for  postmastectomy radiation therapy using EPID-based in vivo dosimetry.
    Kang S; Li J; Ma J; Zhang W; Liao X; Qing H; Tan T; Xin X; Tang B; Piermattei A; Orlandini LC
    J Appl Clin Med Phys; 2019 Oct; 20(10):43-52. PubMed ID: 31541537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Feasibility Study for in vivo Dosimetry Procedure in Routine Clinical Practice.
    Falco MD; Giancaterino S; De Nicola A; Adorante N; De Lorenzo RG; Di Tommaso M; Vinciguerra A; Trignani M; Perrotti F; Allajbej A; Fidanzio A; Greco F; Grusio M; Genovesi D; Piermattei A
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818779201. PubMed ID: 29871570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quasi real time in vivo dosimetry for VMAT.
    Fidanzio A; Porcelli A; Azario L; Greco F; Cilla S; Grusio M; Balducci M; Valentini V; Piermattei A
    Med Phys; 2014 Jun; 41(6):062103. PubMed ID: 24877830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel approach to SBRT patient quality assurance using EPID-based real-time transit dosimetry : A step to QA with in vivo EPID dosimetry.
    Moustakis C; Ebrahimi Tazehmahalleh F; Elsayad K; Fezeu F; Scobioala S
    Strahlenther Onkol; 2020 Feb; 196(2):182-192. PubMed ID: 31925465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Step-and-Shoot IMRT by Siemens Beams: An EPID Dosimetry Verification During Treatment.
    Russo M; Piermattei A; Greco F; Azario L; Orlandini L; Zucca S; Cilla S; Menna S; Grusio M; Chiatti L; Fidanzio A
    Technol Cancer Res Treat; 2016 Aug; 15(4):535-45. PubMed ID: 26134437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cone-beam CT-guided radiotherapy in the management of lung cancer: Diagnostic and therapeutic value.
    Elsayad K; Kriz J; Reinartz G; Scobioala S; Ernst I; Haverkamp U; Eich HT
    Strahlenther Onkol; 2016 Feb; 192(2):83-91. PubMed ID: 26630946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric Comparison of Real-Time MRI-Guided Tri-Cobalt-60 Versus Linear Accelerator-Based Stereotactic Body Radiation Therapy Lung Cancer Plans.
    Wojcieszynski AP; Hill PM; Rosenberg SA; Hullett CR; Labby ZE; Paliwal B; Geurts MW; Bayliss RA; Bayouth JE; Harari PM; Bassetti MF; Baschnagel AM
    Technol Cancer Res Treat; 2017 Jun; 16(3):366-372. PubMed ID: 28168936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verification of planning target volume settings in volumetric modulated arc therapy for stereotactic body radiation therapy by using in-treatment 4-dimensional cone beam computed tomography.
    Takahashi W; Yamashita H; Kida S; Masutani Y; Sakumi A; Ohtomo K; Nakagawa K; Haga A
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):426-31. PubMed ID: 23562767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with EPID dosimetry for prostate IMRT pre-treatment dose verification.
    McDermott LN; Wendling M; van Asselen B; Stroom J; Sonke JJ; van Herk M; Mijnheer BJ
    Med Phys; 2006 Oct; 33(10):3921-30. PubMed ID: 17089854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of interfractional variation of the centroid position and volume of internal target volume during stereotactic body radiotherapy of lung cancer using cone-beam computed tomography.
    Sun Y; Ge H; Cheng S; Yang C; Zhu Q; Li D; Tian Y
    J Appl Clin Med Phys; 2016 Mar; 17(2):461-472. PubMed ID: 27074466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EPID-based in vivo dosimetry using Dosimetry Check™: Overview and clinical experience in a 5-yr study including breast, lung, prostate, and head and neck cancer patients.
    Nailon WH; Welsh D; McDonald K; Burns D; Forsyth J; Cooke G; Cutanda F; Carruthers LJ; McLaren DB; Puxeu Vaqué J; Kehoe T; Andiappa S
    J Appl Clin Med Phys; 2019 Jan; 20(1):6-16. PubMed ID: 30536528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of four-dimensional computed tomography pulmonary ventilation imaging-based functional avoidance for lung cancer radiotherapy.
    Yamamoto T; Kabus S; von Berg J; Lorenz C; Keall PJ
    Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):279-88. PubMed ID: 20646852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In aqua vivo EPID dosimetry.
    Wendling M; McDermott LN; Mans A; Olaciregui-Ruiz Í; Pecharromán-Gallego R; Sonke JJ; Stroom J; van Herk M; Mijnheer BJ
    Med Phys; 2012 Jan; 39(1):367-77. PubMed ID: 22225306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variations of target volume definition and daily target volume localization in stereotactic body radiotherapy for early-stage non-small cell lung cancer patients under abdominal compression.
    Han C; Sampath S; Schultheisss TE; Wong JYC
    Med Dosim; 2017 Summer; 42(2):116-121. PubMed ID: 28433482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Setting up a lung stereotactic body radiotherapy service in a tertiary center in Eastern India: The process, quality assurance, and early experience.
    Shrimali RK; Saha A; Arun B; Prasath S; Nallathambi C; Bhoumik S; Mallick I; Achari RB; Chatterjee S
    J Cancer Res Ther; 2020; 16(4):888-899. PubMed ID: 32930136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External validation of a hidden Markov model for gamma-based classification of anatomical changes in lung cancer patients using EPID dosimetry.
    Wolfs CJA; Varfalvy N; Canters RAM; Nijsten SMJJG; Hattu D; Archambault L; Verhaegen F
    Med Phys; 2020 Oct; 47(10):4675-4682. PubMed ID: 32654162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Craniocaudal safety margin calculation based on interfractional changes in tumor motion in lung SBRT assessed with an EPID in cine mode.
    Ueda Y; Miyazaki M; Nishiyama K; Suzuki O; Tsujii K; Miyagi K
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):1064-9. PubMed ID: 22245190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.